Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Post by MaxPowerJron Jul 10, 2018 12:50pm
208 Views
Post# 28293903

NR Musings and Form 7

NR Musings and Form 7So we have not had our NR...and I believe there is "material" information that is being held back, that is at least one 15,000 order of Reveur - As this is the inaugural first order, and the first large revenue for LDS this is a material event.. but Brad is sitting on this and they are comfortable NOT NR's this! In addition..in Form 7: they extended the performance warrants from June 30 to September 30, 2018 It is evident, that the "new" Cali rules and regs have delayed LDS's revue and business plan by a few months... as evident by the performance extension by 3 months I am now thinking that Brad will WAIT until the 300 litre order is delivered and paid for before releasing their NR. If they are sitting on material news of the Reveur, why disappoint the market on the 300 litre "in the bag" delay??.... Brad told Equity Guru, he was eager to announce revenues.... but I think this was before the new July 1 regs...... plus we know the final product needs final lab testing before this can be finalized which is 5- 14 days!!! So, I am now of the belief...we are day by day probably awaiting for the final lab certification of our 300 litre purity certification..... We will know the NR is coming when volume and price increase (SP leakage)
Bullboard Posts